Skip to main content
Year archive

Swedish Orphan Biovitrum — 2017 filings

All 34 regulatory filings released by Swedish Orphan Biovitrum (SOBI) in 2017, sourced directly from the official regulator.

34 Filings
2017 Period
2017 filings (34)
Filing Released Lang
Major Shareholding Notification 2017
Major Shareholding Notification
2017-12-15 English
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-10-25 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q3 2017
2017-10-25 English
Ändring av antalet aktier och röster i Swedish Orphan Biovitrum AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-08-31 Swedish
New number of shares and votes in Swedish Orphan Biovitrum AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-08-31 English
The board of directors exercises authorization for repurchase of shares to secure the company’s commitments under incentive programme
Transaction in Own Shares
2017-07-19 English
Styrelsen utnyttjar återköpsbemyndigande för säkerställande av bolagets åtaganden enligt incitamentsprogram
Share Issue/Capital Change
2017-07-19 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q2 2017
2017-07-19 Swedish
Earnings Release 2017
Earnings Release H1 2017
2017-07-19 English
Chief Operating Officer Alan Raffensperger to leave Sobi™
Board/Management Information
2017-06-07 English
Chief Operating Officer Alan Raffensperger lämnar Sobi™
Board/Management Information
2017-06-07 Swedish
Sobi™ behåller affärsområdet Partner Products som en integrerad del av företaget
M&A Activity
2017-06-05 Swedish
Sobi™ keeps the Partner Products business area as an integral part of the company
Regulatory Filings
2017-06-05 English
Kommuniké från Swedish Orphan Biovitrums (”Sobi”) årsstämma
AGM Information
2017-05-04 Swedish
Bulletin from Swedish Orphan Biovitrum’s (“Sobi”) Annual General Meeting (AGM)
AGM Information
2017-05-04 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-04-28 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-04-28 English
Annual Report 2016
Annual Report FY 2016
2017-04-12 Swedish
Annual Report 2016
Annual Report FY 2016
2017-04-12 English
Theresa Heggie avgår från styrelsen och kommer inte att föreslås till omval vid Sobis årsstämma 2017
Board/Management Information
2017-04-07 Swedish
Theresa Heggie resigns from the Board of Directors and will not be proposed for re-election at Sobi’s annual general meeting 2017
Board/Management Information
2017-04-07 English
Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
AGM Information
2017-03-30 English
Kallelse till årsstämma i Swedish Orphan Biovitrum AB (publ)
AGM Information
2017-03-30 Swedish
Sobi ™ utökar utvecklingsportföljen inom hemofili B genom att addera rFIXFc-XTEN till samarbetsavtalet med Bioverativ
Regulatory Filings
2017-02-16 Swedish
Sobi™ expands haemophilia B development portfolio by adding rFIXFc-XTEN to its collaboration agreement with Bioverativ
Regulatory Filings
2017-02-16 English
Management Reports 2017
Management Reports
2017-02-16 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report FY 2016
2017-02-16 English
Major Shareholding Notification 2017
Major Shareholding Notification
2017-02-09 English
Uttalandeangående spekulationer kring en eventuell försäljning av affärsområdet PartnerProducts
M&A Activity
2017-02-03 Swedish
Statement regarding speculations on a potential sale of the Partner Products business area
M&A Activity
2017-02-03 English
CEO Geoffrey McDonough to leave Sobi
Board/Management Information
2017-01-09 English
Vd Geoffrey McDonough lämnar Sobi
Board/Management Information
2017-01-09 Swedish
Armin Reininger joins Sobi as Senior Vice President, Head of Global Medical and Scientific Affairs
Board/Management Information
2017-01-05 English
Armin Reininger blir Senior Vice President, Head of Global Medical and Scientific Affairs
Board/Management Information
2017-01-05 Swedish